《BioRxiv,2月25日,(第2版更新)No more business as usual: agile and effective responses to emerging pathogen threats require open data and open analytics》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-26
  • No more business as usual: agile and effective responses to emerging pathogen threats require open data and open analytics

    Galaxy and HyPhy developments teams, Anton Nekrutenko, Sergei L Kosakovsky Pond

    doi: https://doi.org/10.1101/2020.02.21.959973

    Abstract

    The current state of much of the Wuhan pneumonia virus (COVID-19) research shows a regrettable lack of data sharing and considerable analytical obfuscation. This impedes global research cooperation, which is essential for tackling public health emergencies, and requires unimpeded access to data, analysis tools, and computational infrastructure. Here we show that community efforts in developing open analytical software tools over the past ten years, combined with national investments into scientific computational infrastructure, can overcome these deficiencies and provide an accessible platform for tackling global health emergencies in an open and transparent manner. Specifically, we use all COVID-19 genomic data available in the public domain so far to (1) underscore the importance of access to raw data and to (2) demonstrate that existing community efforts in curation and deployment of biomedical software can reliably support rapid, reproducible research during global health crises. All our analyses are fully documented at https://github.com/galaxyproject/SARS-CoV-2.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.biorxiv.org/content/10.1101/2020.02.21.959973v2
相关报告
  • 《BioRxiv,2月22日,No more business as usual: agile and effective responses to emerging pathogen threats require open data and open analytics》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-23
    • No more business as usual: agile and effective responses to emerging pathogen threats require open data and open analytics Galaxy and HyPhy developments teams, Anton Nekrutenko, Sergei L Kosakovsky Pond doi: https://doi.org/10.1101/2020.02.21.959973 Abstract Global cooperation, necessary for tackling public health emergencies such as the Wuhan pneumonia virus (COVID-19) outbreak, requires unimpeded access to data, analysis tools, and computational infrastructure. The current state of much of COVID-19 research shows regrettable lack of data sharing and considerable analytical obfuscation. In this study, we use all COVID-19 genomic data available in the public domain so far to (1) underscore the importance of access to raw data and to (2) demonstrate that existing community efforts in curation and deployment of biomedical software can reliably support rapid, reproducible research during global crises. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《BioRxiv,2月5日,(第2版更新)Genomic variance of the 2019-nCoV coronavirus》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-06
    • Genomic variance of the 2019-nCoV coronavirus Carmine Ceraolo, View ORCID ProfileFederico M Giorgi doi: https://doi.org/10.1101/2020.02.02.931162 Abstract There is rising global concern for the recently emerged novel Coronavirus (2019-nCov). Full genomic sequences have been released by the worldwide scientific community in the last few weeks in order to understand the evolutionary origin and molecular characteristics of this virus. Taking advantage of all the genomic information currently available, we constructed a phylogenetic tree including also representatives of other coronaviridae, such as Bat coronavirus (BCoV) and SARS. We confirm high sequence similarity (>99%) between all sequenced 2019-nCoVs genomes available, with the closest BCoV sequence sharing 96.2% sequence identity, confirming the notion of a zoonotic origin of 2019-nCoV. Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hyper-variable genomic hotspots, one of which is responsible for a Serine/Leucine variation in the viral ORF8-encoded protein. Finally, we perform a full proteomic comparison with other coronaviridae, identifying key aminoacidic differences to be considered for antiviral strategies deriving from previous anti-coronavirus approaches. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.